Massively targeted evaluation of therapeutic CRISPR off-targets in cells
Thorough evaluation of CRISPR RNA-guided nucleases off-targets in cells is required for advancing gene therapies. Here the authors report SURRO-seq for the simultaneous investigation of thousands of off-target sites for therapeutic RNA-guided nucleases in cells.
Main Authors: | Xiaoguang Pan, Kunli Qu, Hao Yuan, Xi Xiang, Christian Anthon, Liubov Pashkova, Xue Liang, Peng Han, Giulia I. Corsi, Fengping Xu, Ping Liu, Jiayan Zhong, Yan Zhou, Tao Ma, Hui Jiang, Junnian Liu, Jian Wang, Niels Jessen, Lars Bolund, Huanming Yang, Xun Xu, George M. Church, Jan Gorodkin, Lin Lin, Yonglun Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-31543-6 |
Similar Items
-
CRISPR/Cas9 gRNA activity depends on free energy changes and on the target PAM context
by: Giulia I. Corsi, et al.
Published: (2022-05-01) -
Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning
by: Xi Xiang, et al.
Published: (2021-05-01) -
CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters
by: Ferhat Alkan, et al.
Published: (2018-10-01) -
Comparison of In-Frame Deletion, Homology-Directed Repair, and Prime Editing-Based Correction of Duchenne Muscular Dystrophy Mutations
by: Xiaoying Zhao, et al.
Published: (2023-05-01) -
The single-cell expression profile of transposable elements and transcription factors in human early biparental and uniparental embryonic development
by: Conghui Li, et al.
Published: (2022-11-01)